News About: Pharm. Industry
Drugmakers, wholesalers to face joint anti-rebate investigations
Sooner or later, pharmaceutical companies and wholesalers are likely to face the government’s intensive campaigns aimed at curbing rebates and lowering drug prices.
Participating in this campaign are not just the ...
GSK to strengthen presence in Asia with new strategic alliance with Dong-A
With a strategic alliance with Dong-A Pharmaceuticals Co. (Dong-A) in May, GlaxoSmithKline (GSK) has a plan to promote the latter’s proprietary and generic pharmaceutical products and leading consumer healthcare brand...
Green Cross, MacroGenics sign exclusive license agreement to develop and commercialize Herceptin Bio
Green Cross Corporation and US-based MacroGenics Inc. announced on July 8 an agreement to grant Green Cross exclusive rights to develop and commercialize MGAH22, a next-generation and Fc-optimized mAB that targets HER...
Deregulation on joint, commissioned bioequivalence testing stirs debate
The government’s plan to deregulate the joint, commissioned bioequivalence testing has stirred up concerns among drug companies.
They fear that the new plan could not only slash their profits amid entry of too many...
KFDA nods Amosartan as first-line antihypertensive drug
The Korea Food and Drug Administration approved the homegrown anti-hypertension combination drug “Amosartan” as a first-line drug in patients with more than moderate hypertension (systolic blood pressure; more than 16...
Korea veers into health food market
A local professor said Korea will enter the promising health food market together with local research institutes backed by the government, it was learned on July 7.
The Ministry of Knowledge Economy said it would ...
Kanab picked as brand name of new antihypertensive agent
Boryung Pharmaceutical Co., one of Korea's largest pharmaceutical companies, said on July 7 that it has finally selected the brand name of its novel antihypertensive drug as “Kanarb” after a one-month public contest. ...
Controversies arise over drug card mileage
The Health Ministry has recently decided to accept the official use of card mileage by pharmacies, which will be provided by wholesalers.
In a meeting with representatives from the Korean Pharmaceutical Association...
AZ recruits Korean scientists
AstraZeneca Korea said it will recruit promising Korean scientists who are involved in the research and development of cardiovascular disease, diabetes and obesity from July 5 to August 31 this year.
AstraZeneca, t...
KPMA names 10 vice chairmen
The Korea Pharmaceutical Manufacturers Association nominated 10 new vice chairmen from its member companies, it was learned on July 6.
During its fourth board of directors meeting, the KPMA elected them from ten co...
